www.iflo.com

Home: Info: News Releases: 2004 Archives

Press Releases 2004 Archives

December 8, 2004
ON-Q Offered As Post-Surgical Standard of Care for Surgeries Performed at Beverly Hills Surgical Institute

December 3, 2004
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the First Albany Capital Annual Growth Conference, Wednesday afternoon, December 8, 2004 at 3:20 p.m. EST.

November 30, 2004
I-Flow Corporation (NASDAQ: IFLO) announced today a national agreement with Aetna to make I-Flow's InfuSystem service for oncology therapy delivery available. InfuSystem's service is the safest and most effective method of chemotherapy delivery and helps physicians better manage their patients' therapy and monitor outcomes.

November 24, 2004
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the First Annual Lazard Life Sciences Conference, Tuesday afternoon, November 30, 2004 at 2:00 p.m. EST.

November 12, 2004
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the SG Cowen 5th Annual Global Health Care Conference, Wednesday morning, November 17, 2004 at 3:45 a.m. EST.

November 9, 2004
I-Flow Views Decision as Initial Step toward Widespread Medicare Policy and Broader Private Insurance Coverage

November 4, 2004
Nine-Month Revenue Increased 50% to a Record $50 Million On 102% Increase in Regional Anesthesia Sales; Oncology Infusion Services Third Quarter Revenue Increased 59% to A Record $5.2 Million

November 1, 2004
I-Flow Corp. (NASDAQ: IFLO) today announced an agreement with Novation LLC to make
ON-Q(R) PainBuster(R), a narcotic-free surgical-site pain relief system used after surgery, available to health care organizations that purchase supplies through Novation, the leading supply services
company in health care.

October 27, 2004
I-Flow Corporation (NASDAQ: IFLO) today announced that the results of a study conducted at Washington University School of Medicine in St. Louis examining surgical incision healing with ON-Q(R) PainBuster(R) have been presented at the American Society of Anesthesiologists Annual Meeting.

October 21, 2004
Study Results Featuring ON-Q PainBuster Following Gynecologic Oncology Surgery Presented at ACOG Divisional Meeting

October 19, 2004
I-Flow Receives European Union CE Mark Clearance for ON-Q to Significantly Reduce Post-Surgical Pain and Narcotic Use

October 11, 2004
Landmark Study Shows ON-Q PainBuster Effectively Treats Pain While Minimizing or Eliminating Narcotic Use Following Robotic Radical Prostatectomy

September 29, 2004
I-Flow To Be Awarded Deloitte Technology's Fast 50 Recognition During October 4th Awards Ceremony

September 15, 2004
I-FLOW CORPORATION (Nasdaq:IFLO) announced today that it will address institutional shareholders at the Merriman Curhan Ford & Co. Investor Summit 2004 on Monday, September 20, 2004 at 12:30 p.m. PDT.

September 14, 2004
Surgeons on the Medical Staff at Baylor Dallas Enhance Satisfaction and Outcomes by Enabling Some Patients to Get Back to Normal Faster

September 10, 2004
I-Flow Corporation (Nasdaq:IFLO) announced today that it will address institutional shareholders at the Roth Capital Partners New York Conference on Monday, September 13, 2004, at 9:00 a.m. EDT.

August 19, 2004
I-Flow Corporation (NASDAQ:IFLO) today announced that Dr. Dana Mears, an orthopedic surgeon practicing at UPMC Presbyterian-Shadyside Hospital in Pittsburgh, has incorporated the ON-Q(R) Post-Operative Pain Relief System into his innovative outpatient total hip replacement surgery program.

August 10, 2004
I-Flow Establishes Relationship with MedAssets to Promote ON-Q's Significantly Better Post-Surgical Pain Relief

July 27, 2004
I-Flow Corporation (NASDAQ:IFLO) announced today that revenue for the second
quarter of 2004 increased 51% to $17,167,000, as compared to the second quarter of last year, driven by a 96% increase in Regional Anesthesia sales.

July 27, 2004
I-Flow Corporation (Nasdaq:IFLO) announced today that its Board of Directors
has authorized the repurchase of up to one million shares of the Company's common stock

July 21, 2004
plans to release financial results for the second quarter ended June 30, 2004

June 4, 2004
Nearly seventy million Americans will undergo some type of surgery this year.

May 25, 2004
ON-Q First in Device Classification to Receive Expanded Indications for Use for Reduction of Post-Surgical Narcotics

May 20, 2004
Study Finds Narcotic-Free ON-Q PainBuster Reduces Post-Surgical Pain Following Cesarean Section and Provides Patients Additional Long-Term Pain Benefits

May 17, 2004
Interim Data of Over 200 Patients Featured by World-Renowned Urologist in Conjunction with American Urological Association Meeting

May 4, 2004
Consorta to Make the Benefits of ON-Q PainBuster Available to over 400 Acute Care Facilities

April 27, 2004
I-Flow's First Quarter Revenue Increased 40% to a Record $14.2 Million On a 90% Increase in Regional Anesthesia Sales; ON-Q Sales Growth Drives Ninth Consecutive Quarter of Record Revenue

April 23, 2004
I-Flow Corporation To Release First Quarter

April 22, 2004
Benefits of ON-Q PainBuster Presented at Annual Meeting of the American Society for Aesthetic Plastic Surgery

April 19, 2004
I-Flow Corporation Completes Stock Offering

April 13, 2004
I-Flow Corporation Announces Common Stock Offering

March 23, 2004
I-Flow Corporation Announces Public Offering of Common Stock

February 24, 2004
I-Flow's Regional Anesthesia Sales Gain 125%, Propel Fourth Quarter Total Revenue 46% to Record $13.7 Million; ON-Q Sales Ramp Sets Pace for Eighth Consecutive Quarter of Record Revenue

February 23, 2004
I-Flow Corporation To Release Fourth Quarter, 2003 Results

February 17, 2004
Miami Children's Hospital Begins Research Study of Promising ON-Q PainBuster Post-Surgical Pain Relief Device, New for Pediatric Patients

February 11, 2004
I-Flow Will Present at The 16th Annual Roth Capital Partners Growth Stock Conference

January 22, 2004
I-Flow Explores New Reimbursement Options for ON-Q Customers

January 21, 2004
I-Flow Renames Flagship Entry in Fast-Growing ON-Q Brand

There are inherent risks in all medical devices, please refer to the product labeling for Indications, Cautions, Warnings and Contraindications.For example, failure to follow the product labeling regarding filling, flow rate selection and placement of the pump and/or catheter could directly impact patient safety. Physician is responsible for prescribing and administering medications per instructions provided by the drug manufacturer.